ASMB

Assembly Biosciences Inc.

Price

$32.95

return (12m)

29.52%

p/e

p/bv

1.98

DIVIDEND YIELD

0.00%

ASMB price

Assembly Biosciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ASMB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

27.81%

3 months

20.17%

1 year

29.52%

2 years

130.42%

5 years

-25.18%

10 years

-58.01%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ASMB

Valuation

P/E

Sector -4.39

Industry -4.39

P/BV

1.98

Sector 2.03

Industry 2.03

P/Revenue (PSR)

8.08

Sector -4.47

Industry -4.47

EV/EBITDA

-45.03

Sector -265.17

Industry -265.17

EV/EBIT

-44.89

Sector -704.60

Industry -704.60

P/EBITDA

-69.70

Sector -4.39

Industry -4.39

P/EBIT

-68.82

Sector -4.73

Industry -4.73

P/Total Assets

1.83

Sector 1.49

Industry 1.49

P/Net Current Assets

2.00

Sector -11.73

Industry -11.73

P/Working Capital

1.99

Sector -3.02

Industry -3.02

EPS

0.00

Sector -2.14

Industry -2.14

BVPS

16.09

Sector 1.86

Industry 1.86

Efficiency

Gross Margin

100.00%

Sector 36.61%

Industry 36.61%

EBITDA Margin

-47.27%

Sector -16,313.59%

Industry -16,313.59%

EBIT Margin

-47.42%

Sector -4,256,416.89%

Industry -4,256,416.89%

Operating Margin

-11.75%

Sector -38.06%

Industry -38.06%

Net Profit Margins

-0.07%

Sector -39.54%

Industry -39.54%

Asset Turnover

0.04

Sector 0.03

Industry 0.03

Profitability

ROE

-0.02%

Sector -65.39%

Industry -65.39%

ROA

-0.02%

Sector -65.45%

Industry -65.45%

ROIC

-87.87%

Sector -2,109.21%

Industry -2,109.21%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

13.99

Sector 2.90

Industry 2.90

Net Debt / EBITDA

50.69

Sector -6.09

Industry -6.09

Net Debt / EBIT

50.53

Sector -3.13

Industry -3.13

Net Debt / Equity

-1.05

Sector -1.08

Industry -1.08

Gross Debt / Equity

0.00

Sector 0.00

Industry 0.00

Equity/Assets

0.92

Sector 0.41

Industry 0.41

Liabilities/Assets

0.08

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

64.30%

Sector -

Industry -

5Y Earnings CAGR

-79.25%

Sector -

Industry -

Fundamentals ASMB

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ASMB Assembly Biosciences Inc.	$32.95	29.52%	0.00%	0.00	1.98	-0.02%	-0.07%
JNJ Johnson & Johnson	$260.35	51.88%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$26.79	16.04%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$249.45	24.54%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.89	-7.06%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$135.84	67.77%	2.52%	103.94	7.86	7.56%	4.77%
AZN AstraZeneca PLC	$156.45	1.21%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$63.83	38.02%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$73.79	-51.04%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$803.48	39.19%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$415.21	45.14%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$98.66	46.66%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$869.00	29.78%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$505.75	28.76%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$235.17	59.19%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$38.12	3.39%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$209.83	51.39%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ASMB Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Assembly Biosciences

Assembly Biosciences Inc.

Average Investor10 user rating

4.0 (2 people)

United States

21 years

Founded: 2005

2010

Time since IPO - 16 years

139

Employees

Assembly Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $604.96 million, with shareholders equity totaling $305.65 million.

The company employs approximately 139 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Assembly Biosciences Inc. reported $74.84 million in revenue, generating net income of $-50.00 Thousand.

Key financial metrics include a P/E ratio of -, a price-to-book (P/B) ratio of 1.98, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ASMB.

Market cap

$604.96 million

Net worth

$305.65 million

$305,650,000.00

Assets

$330.83 million

$330,830,000.00

Total Shares Outstanding

19.00 million

19,000,000

Average Daily Trading Volume

$219.14 Thousand

$219,140.00

Sector

Health Care

Industry

Biotechnology

ASMB

ASMB revenue and profits

Financial Results ASMB

DRAG THE FRAME TO SEE MORE DATA

ASMB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$869.00 29,78% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$235.17 59,19% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$260.35 51,88% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$249.45 24,54% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$135.84 67,77% (12M)

P/E

103.94

2.52%

ROE

7.56%

P/BV

7.86

AZN - AstraZeneca

$156.45 1,27% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$26.79 16,04% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$869.00 29,78% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$235.17 59,19% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$260.35 51,88% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$249.45 24,54% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$135.84 67,77% (12 M)

P/L

103.94

2.52%

ROE

7.56%

P/VP

7.86

AZN - AstraZeneca

$156.45 1,27% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$26.79 16,04% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Assembly Biosciences (ASMB) today?

A cotação de Assembly Biosciences (ASMB) hoje está em US$ 32.95, com uma variação de 29.52% em relação ao último ano. A cotação de Assembly Biosciences (ASMB) iniciou o ano negociando na casa dos US$ 34.01 e hoje está em US$ 32.95. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Assembly Biosciences (ASMB) e dados de ações do Ibovespa e mercados internacionais.

Quando Assembly Biosciences (ASMB) paga dividendos?

Assembly Biosciences (ASMB) não distribuiu dividendos no último ano.

Is Assembly Biosciences (ASMB) a good investment?

Atualmente, Assembly Biosciences (ASMB) está cotada a US$ 32.95, com um P/L de 0.00, representando um desvio de -1,762% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 29.52 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 29.52%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Assembly Biosciences (ASMB) stock?

Investir em ações de Assembly Biosciences (ASMB) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Assembly Biosciences (ASMB) yield today?

A rentabilidade de Assembly Biosciences (ASMB) foi de 27.81% no último mês, 29.52% no último ano e -25.18% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Assembly Biosciences (ASMB) hoje, o investimento total seria de US$ 3,295.00, com base na cotação atual de US$ 32.95.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 4,267.68
Em 5 anos: US$ 2,465.32
Em 10 anos: US$ 1,383.57

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ASMB

Assembly Biosciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ASMB

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ASMB WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Assembly Biosciences

Assembly Biosciences Inc.

United States

21 years

2010

139

PROFIT X PRICE ASMB

Financial Results ASMB

ASMB cash flow

Asset, Revenue and Profit Growth - ASMB

ASMB balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions